News
-
05 December 2013
NovaMedica LLC, a Russian pharmaceutical company, has signed a partnership agreement with Aptalis Pharma, a leading specialty pharmaceutical company, providing innovative, effective therapies for unmet medical needs, to develop and commercialize a portfolio of three of Aptalis Pharma’s novel gastrointestinal pharmaceutical products in Russia.
-
05 November 2013
NovaMedica is expected to launch its first portfolio products in H1 2014 and own developments are expected to launch in 1,5-2 years, - said Vladimir Gurdus, CEO of D-Pharma, Management Company of RMI LLC and NovaMedica LLC at Pharma Russia Conference hosted by the newspaper “Vedomosti”.
-
31 July 2013
NovaMedica, a Russian pharmaceutical and medical device company, and ReVision Optics, Inc. the U.S. developer of the innovative refractive surgery solution against presbyopia Raindrop™ Near Vision Corneal Inlay, have signed an agreement to commercialize this technology in Russia.
-
25 July 2013
NovaMedica, Kaluga Region and City of Kaluga Sign Agreement on Construction of Pharmaceutical Plant
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.
-
24 June 2013
Leonid Melamed, Chairman of the Board of Directors, Team Drive, and Member of the Board of Directors, RMI and NovaMedica: The environment must be designed for delivering ideas and people for innovations; this objective and KPI of the Ministry of Education could be achieved through joining of several Russian universities the top 100 world universities".
-
24 June 2013
During SPIEF 2013 panel “Knowledge-based economy – a strategy for getting ahead of the curve”, one of the moderators of which was Leonid Melamed (Member of the Board of Directors, RMI and NovaMedica; Chairman of the Board of Directors, Team Drive), the panelists featuring science, education, government and investment banking have shared their views on the viability and prospects for further development of the knowledge-based economy in Russia as the highest stage in the development of innovative economy putting together specific proposals/ideas in favor of their viewpoints.
-
24 June 2013
Leonid Melamed, Chairman of the Board of Directors, Team Drive; Member of the Board of Directors, RosnanoMedInvest an NovaMedica: "The State policy shall be focused on having as much elements in the pharmaceutical value creation chain concentrated in the hands of as many Russia-based companies paying taxes in Russia as possible."
-
25 April 2013
New pharmaceutical company NovaMedica is an integral part of this Russian Government’s Healthcare strategy within “Russia 2020” that will boost growth in the Pharmaceutical Market for the next 10 years.
-
19 April 2013
Announce: Novamedica on BIO 2013: Spotlight On The BRICs. Russia
BIO International Convention (BIO-2013). Chicago, USA. Special session «Spotlight on the BRICs: Russia» Monday, Apr 22, 2013
-
18 April 2013
NovaMedica launches its website using a new domain name www.novamedica.com
Pharmaceutical company NovaMedica announces the launch of its website using a new domain name www.novamedica.com. One of the main reasons for moving the website to a new domain that would be more consistent with the ñompany’s name is our desire to offer our current and potential partners an easier access to the information about the ñompany.
All Portfolio
MEDIA CENTER
-
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.